Nosocomial lung infections in adult intensive care units

Microbes and Infection
Gonzalo HernándezJ Rello

Abstract

Nosocomial respiratory tract infections are the leading type of nosocomial infections. Despite the development of new antibiotic therapies, they are associated with an increased morbidity and mortality. Patients with comorbidities are especially predisposed to acquire these infections, as are patients exposed to respiratory therapy. Aspiration of colonized secretions from the oropharynx is the main mechanism of infection development. Barrier techniques to reduce aspiration and antimicrobial agents to alter bacterial flora are important in preventing pneumonia episodes. The initial institution of an adequate antibiotic regimen is a determinant of outcome. Nosocomial pneumonias are often difficult to treat due to antibiotic-resistant bacteria. Antibiotic policies are crucial in avoiding a progression in antibiotic resistance.

References

Sep 1, 1990·The American Review of Respiratory Disease·A TorresR Rodriguez-Roisin
Jan 1, 1990·Chest·M S NiedermanD E Schultz
Oct 1, 1984·The American Journal of Medicine·R D MooreP S Lietman
Aug 1, 1995·American Journal of Respiratory and Critical Care Medicine·K R SutherlandL D Hudson
Dec 1, 1994·American Journal of Respiratory and Critical Care Medicine·J RelloR Rodriguez-Roisin
Oct 27, 1993·JAMA : the Journal of the American Medical Association·M H Kollef
Jan 1, 1993·The American Review of Respiratory Disease·P MontraversC Gibert
Jul 1, 1996·American Journal of Respiratory and Critical Care Medicine·J RelloJ Vallés
Mar 1, 1996·Dimensions of Critical Care Nursing : DCCN·R S Goodwin
Apr 1, 1996·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·P K LindenS Kusne
Feb 1, 1997·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·L ArchibaldR Gaynes
May 1, 1997·American Journal of Respiratory and Critical Care Medicine·J M SirventA Bonet
Jul 1, 1997·American Journal of Respiratory and Critical Care Medicine·J RelloJ Valles
Dec 31, 1997·American Journal of Respiratory and Critical Care Medicine·M Garrouste-OrgeasB Schlemmer
Feb 26, 1998·American Journal of Respiratory and Critical Care Medicine·J L TrouilletC Gibert
Mar 21, 1998·JAMA : the Journal of the American Medical Association·D CookC Brun-Buisson
Mar 28, 1998·American Journal of Respiratory and Critical Care Medicine·J RelloP Coll
May 1, 1998·American Journal of Respiratory and Critical Care Medicine·J ChastreC Gibert
May 1, 1998·American Journal of Respiratory and Critical Care Medicine·A H MertensD Coolen
Jun 23, 1998·Diagnostic Microbiology and Infectious Disease·R N Jones, M A Pfaller
Aug 26, 1998·Emerging Infectious Diseases·R A Weinstein
Sep 12, 1998·Annals of Internal Medicine·D J CookC Brun-Buisson
Nov 4, 1998·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·J Rello, J Valles
Nov 25, 1998·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·J R ReesA L Reingold
Dec 16, 1998·American Journal of Respiratory and Critical Care Medicine·D L GeorgeC G Mayhall
Mar 13, 1999·International Journal of Antimicrobial Agents·J W Chow, V L Yu
Apr 8, 1999·American Journal of Respiratory and Critical Care Medicine·D K HeylandC Brun-Buisson

❮ Previous
Next ❯

Citations

Sep 7, 2006·Journal of Clinical Microbiology·Almos KleknerJudit Szabo
Dec 6, 2008·Journal of Critical Care·Mathieu BeaulieuJean Lachaine
Mar 22, 2016·Expert Opinion on Investigational Drugs·Vicenç FalcóBenito Almirante
Feb 23, 2011·Revista latino-americana de enfermagem·Adriana Cristina de OliveiraRobert Aldo Iquiapaza
Aug 13, 2005·Critical Care Medicine·Pamela A Lipsett
Apr 4, 2006·Current Opinion in Pulmonary Medicine·Pieter DepuydtStijn Blot

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carbapenems

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Acinetobacter Infections

Acinetobacter infections have become common in hospitalized patients, especially in the intensive care unit setting and are difficult to treat due to their propensity to develop antimicrobial drug resistance. Discover the latest research on Acinetobacter Infections here.

Bacterial Pneumonia (ASM)

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Bacterial Pneumonia

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Cellulitis

Cellulitis (erysipelas) is a recurring and debilitating bacterial infection of the skin and underlying tissue. Discover the latest research on cellulitis here.

Carbapenems (ASM)

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

© 2021 Meta ULC. All rights reserved